Sociedad Argentina de Hematología

 

 

 

 

 

 

 

 

 

 

 

ISSN 2250-8309

 

Formulario de cesión
de Derechos de Autor

Se solicita enviar el siguiente formulario, debidamente firmado por todos los autores del trabajo presentado

por Fax (11) 48552452

o personalmente en la SAH
o en archivo PDF por mail

Formulario de Cesión de Derechos de Autor

 

 

  REVISTA ARGENTINA DE HEMATOLOGÍA                                                                                    « Back »

Volumen:    21    # Number : 1

Publication Date :    ENERO - ABRIL    Year:    2017

   ATENEO

Dasatinib-associated hemorrhagic colitis in Philadelphia positive Acute Lymphoblastic Leukemia (Ph + ALL): A case report
Authors: Guerra, V; Romagnoli, C; Romero, E; Lo Turco, A; Courreges, V; Fuente L

Abstract: The Philadelphia chromosome (Ph) is the cytogenetic anomaly most commonly found in patients with acute lymphoblastic leukemia (ALL). The result of this mutation is the BCR-ABL protein, an active kinase involved in cell signaling and survival. Dasatinib is a second-line tyrosine kinase inhibitor used in patients with imatinib resistance or intolerance with chronic myeloid leukemia (CML) and ALL Ph+. Side effects of this drug include myelosuppression, pleural effusion, diarrhea, and liver enzyme abnormalities. Gastrointestinal bleeding may occur with the use of dasatinib, but is generally mild and easily handled. Nevertheless, there are a few case reports of severe acute colitis related to dasatinib. We present the case of a 55-year-old male with diagnosis of ALL Ph+ that presented hemorrhagic colitis after 3 months of treatment with dasatinib. Clostridium difficile, citomegalovirus and other enteric pathogens infections were discarded. Video colonoscopy evidenced pancolitis and the pathological anatomy revealed acute exacerbation of chronic colitis. With other causes discarded, dasatinib treatment was stopped with clinical improvement within 72 hours.

Key words: Acute lymphoblastic leukemia Philadelphia chromosome positive (ALL Ph+) Dasatinib Hemorrhagic colitis.

Pages :

  Resumen             pdf  

SOCIEDAD ARGENTINA DE HEMATOLOGÍA
Julián Alvarez 146 - Ciudad Autónoma de Bs As - Argentina
(54-11) 4855-2452 / 2485

http://www.sah.org.ar/revista/